Long-term stability of sodium folinate in dextrose 5% polyolefin bags at 4°C

Journal of Oncology Pharmacy Practice

Volumn 13, Issue 2, 2007, Pages 99-103

  Cadrobbi, Julie ^a   Hecq, Jean Daniel ^a   Vanbeckbergen, Danielle ^a   Jamart, Jacques ^a   Galanti, Laurence ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Centralized intravenous admixture service; High performance liquid chromatography; Long term stability; Sodium folinate

Indexed keywords

FOLINIC ACID; GLUCOSE; POLYOLEFIN; UNCLASSIFIED DRUG; VORINA;

ARTICLE; ASEPSIS; CANCER CHEMOTHERAPY; COLOR; CONTROLLED STUDY; DRUG POTENCY; DRUG SOLUTION; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW TEMPERATURE; PH MEASUREMENT; PRECIPITATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SHELF LIFE; STORAGE TEMPERATURE; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; GLUCOSE; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; LEUCOVORIN; POLYENES; SOLUTIONS; TEMPERATURE; VITAMIN B COMPLEX;

EID: 34548651502     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155207080118     Document Type: Article

References (26)

1. Hooijberg JH, de Vries NA, Kaspers GJL, Pieters R, Jansen G, Peters GJ. Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment. Cancer Chemother Pharmacol 2006; 58: 1-12.
2. Bertino JR. Rescue techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment. Semin Oncol 1977; 4: 203-16.
3. Machover D, Schwartzenberg L, Goldschmidt E et al. Treatment of advanced colorectal and gastric carcinomas with 5-fluorouracil combined with high-dose folinic acid. A pilot study. Cancer Treat Rep 1982; 66: 1803-7.
4. QUASAR Collaborative Group. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer, a randomised trial. Lancet 2000; 355: 1588-96.
5. The Meta-Analysis Group in Cancer. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an update meta-analysis. J Clin Oncol 2004; 22: 3766-75.
6. Folinic acid, uses and administration. MICROMEDEX(R) Healthcare Series Volume 128.
7. Koundalijan J. Setting up a CIVAS. In Needle R, Sizer T eds. The CIVAS Handbook 1998; 1st edition, London, Pharmaceutical Press, 1998: 1-5.
8. Galanti LM, Hecq JD, Vanbeckbergen D et al. Long-term stability of cefuroxime and cefazolin sodium in intravenous solutions. J Clin Pharm Ther 1996; 21: 185-9.
9. Galanti LM, Hecq JD, Vanbeckbergen D et al. Assessment of the stability of teicoplanin in intravenous infusions. Int J Pharmaceut Compound 2001; 5: 397-400.
10. Boitquin LP, Hecq JD, Evrard JM et al. Long-term stability of sufentanil citrate with levobupivacaine HCl in NaCl 0.9% infusion PVC bags at 4°C. J Pain symptom Manage 2004; 28: 4-6.
11. Hecq JD, Schlesser V, Vanbeckbergen D et al. Effect of freezing, long-term storage and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags. Eur J Hosp Pharm S 2005; 11: 23-5.
12. Rodenbach MP, Hecq JD, Vanbeckbergen D et al. Effect of freezing, long term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions. Eur J Hosp Pharm S 2005; 11: 111-13.
13. Hecq JD, Boitquin LP, Vanbeckbergen D et al. Effect of freezing long-term storage, and microwave thawing on the stability of ketorolac tromethamine. Ann Pharmacother 2005; 39: 1654-58.
14. Hecq JD, Boitquin LP, Vanbeckbergen D et al. Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C. Ann Pharmacother 2005; 39: 1244-48.
15. Rodenbach MP, Hecq JD, Vanbeckbergen D et al. Stability of cefuroxime infusion: the brand-name versus a generic product. Eur J Hosp Pharm S 2006; 12: 16-18.
16. Williams DA. Drug stability and compatibility in oncology care. J Infus Chemother 1996; 6: 195-202.
17. Benvenuto JA, Adams SC, Vyas HM et al. Pharmaceutical issues in infusion chemotherapy stability and compatibility. In Lockich JJ ed. Cancer Chemotherapy by Infusion. Precept Press, Inc., 1987: 100-13.
18. Benvenuto JA, Anderson RW, Kerkof K et al. Stability and compatibility of antitumor agents in glass and plastic containers. Am J Hosp Pharm 1981; 38: 1914-18.
19. Lecompte D, Bousselet M, Gayrard D et al. Stability study of reconstituted and diluted solutions of calcium folinate. Pharm Ind 1991; 53: 90-4.
20. Kleinberg ML, Chang P. Overfill of common piggybag admixture solutions. Hosp Pharm 1984; 19: 657-8.
21. Guideline for submitting documentation for the stability of human drugs and biologics. Rockville, MD: Food and Drug Administration, 1987. Retrieved 25 July 2005, from www.fda.gov/cder//guidance/cmc2.pdf.
22. Ruberg SJ, Stegeman JW. Pooling data for stability studies: testing the equality of batch degradation slopes. Biometrics 1991; 47: 1059-69.
23. Giraud C, Adam D. Les solutes en perfusion. In Dauphin A. Pharmascopie soins et therapies collection sous la directopn. Edition Arnette, 1998: 321-31.
24. Trissel LA. The new National Standard for sterile preparation. Hosp Pharm 2004; 39: 900-4.
25. Delaney T. EAHP survey of hospital-based pharmaceutical services in Europe-1996. Eur J Hosp Pharm 1996; 2: 92-105.
26. Hecq JD. Ten years of European hospital pharmacy history: centralized intravenous additives services. Eur J Hosp Pharm 2004; 10: 47.